0001356710-20-000002.txt : 20201218 0001356710-20-000002.hdr.sgml : 20201218 20201218162401 ACCESSION NUMBER: 0001356710-20-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201216 FILED AS OF DATE: 20201218 DATE AS OF CHANGE: 20201218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weldon Steven W CENTRAL INDEX KEY: 0001356710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 201400901 MAIL ADDRESS: STREET 1: 7280 WESTPOINTE BLVD STREET 2: APT 831 CITY: ORLANDO STATE: FL ZIP: 32835 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9350 WILSHIRE BLVD. STREET 2: SUITE 203 CITY: BEVERLY HILLS STATE: CA ZIP: 90212 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 9350 WILSHIRE BLVD. STREET 2: SUITE 203 CITY: BEVERLY HILLS STATE: CA ZIP: 90212 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-12-16 0 0000109657 GT Biopharma, Inc. GTBP 0001356710 Weldon Steven W 401 EAST JACKSON STREET SUITE 2340 TAMPA FL 33602 0 0 0 1 Former Officer and Director Common Stock 2020-12-16 4 S 0 50000 0.3 D 4053700 D Common Stock 2020-12-17 4 S 0 50000 0.3 D 4003700 D Common Stock 2020-12-17 4 S 0 50000 0.31 D 3953700 D Common Stock 2020-12-18 4 S 0 50000 0.3 D 3903700 D . The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Steven Weldon 2020-12-18